The Use of Direct-to-Patient Methods in Decentralized Clinical Trials in Israel
Direct-to-Patient
Clinical trials are essential for advancing medical science and developing new treatments. However, patient recruitment and retention have long been significant challenges in the clinical research process. Direct-to-patient (DtP) approaches seek to address these issues by engaging patients directly in clinical trials, outside the traditional healthcare system. In Israel, a country known for its thriving healthcare and life sciences sector, the adoption of DtP strategies in clinical trials is of particular interest.
Related Education Resources.
All Resources4G Clinical webinar - Mitigating Clinical Supply Chain Risk as the Pandemic Continues
Topics: COVID-19, Project Management, Supply Chain
Webinar
Free
Video on eTMF Requirements provided by Steve Jacobs, Chairman at Global BioPharm Solutions.
Topics: Pharma Industry, Strategic Planning
Video
Members
GDPR Considerations for DtP Supply Chains
Topics: Regulatory, Supply Chain
Guidance Document
Free